BIOVIE INC.

For the period ended Jun 30, 2025. Filed Aug 15, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Aug 15, 2025

BIVI$1.30-2.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Statements of Operations and Comprehensive Loss

	Year Ended	Year Ended
	June 30, 2025	June 30, 2024
OPERATING EXPENSES:
Amortization of intangible assets	$229,377	$229,377
Research and development expenses	9,266,734	23,100,394
Selling, general and administrative expenses	8,570,089	8,849,814
TOTAL OPERATING EXPENSES	18,066,200	32,179,585
LOSS FROM OPERATIONS	(18,066,200)	(32,179,585)
OTHER EXPENSE (INCOME):
Change in fair value of derivative liabilities	(3,771)	(1,816,271)
Interest expense	332,720	2,893,922
Interest income	(853,029)	(1,136,703)
TOTAL OTHER INCOME , NET	(524,080)	(59,052)
NET LOSS	$(17,542,120)	$(32,120,533)
Deemed dividend related to ratchet adjustment to warrants	369,465	886,423
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$(17,911,585)	$(33,006,956)
NET LOSS PER COMMON SHARE
- Basic	$(12.12)	$(73.05)
- Diluted	$(12.12)	$(73.05)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
- Basic	1,477,372	451,853
- Diluted	1,477,372	451,853
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$(17,911,585)	$(33,006,956)
Other comprehensive loss
Reclassification of unrealized gains on available-for-sale investments upon settlement	-	(176,591)
Total other comprehensive loss	-	(176,591)
Comprehensive loss	$(17,911,585)	$(33,183,547)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.